Bloomberg BNA Quotes Life Sciences Partner on 2016 Medical Device Law Trends

In The News
January 12, 2016

Bloomberg BNA Medical Devices Law & Industry Report quoted life sciences partner Gregory Levine (Washington, D.C.) in a column on 2016 medical device law trends. Mr. Levine predicts that the FDA will continue to advance its proposed framework on laboratory-developed tests (LDTs), while lab groups will continue to threaten litigation and the FDA will continue enforcement against direct-to-consumer laboratory tests. (Subscription required)